Sonnet BioTherapeutics Announces $888 Million Merger to Launch HYPE Crypto Reserve
Sonnet BioTherapeutics plans a $888 million business combination to create a public cryptocurrency treasury company, Hyperliquid Strategies Inc., holding a significant reserve of HYPE tokens and cash to enhance its strategic position in digital assets, while continuing its biotech operations.